A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma

Annals of Oncology

Volumn 15, Issue 6, 2004, Pages 947-954

  Lee, J L ^a,c   Park, S I ^a   Kim, S B ^a   Jung, H Y ^a   Lee, G H ^a   Kim, J H ^a   Song, H Y ^a   Cho, K J ^b   Kim, W K ^a   Lee, J S ^a   Kim, S H ^a   Min, Y I ^a  

^a Ulsan College   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c Yeungnam University College of Medicine   (South Korea)

Author keywords

Combined modality therapy; Esophageal cancer; Neoadjuvant therapy; Randomized controlled trial; Squamos cell carcinoma

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG RESPONSE; ESOPHAGITIS; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; ESOPHAGUS STRICTURE; FEMALE; FOLLOW UP; HEART INFARCTION; HOARSENESS; HUMAN; INTERMETHOD COMPARISON; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MUCOSA INFLAMMATION; NAUSEA AND VOMITING; NEUTROPENIA; PATIENT COMPLIANCE; PHASE 3 CLINICAL TRIAL; PNEUMONIA; POSTOPERATIVE COMPLICATION; PREOPERATIVE CARE; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RANDOMIZED CONTROLLED TRIAL; SQUAMOUS CELL CARCINOMA; THROMBOCYTOPENIA; TREATMENT FAILURE; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS; VOCAL CORD PARALYSIS; WOUND DEHISCENCE;

EID: 3442899114     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdh219     Document Type: Article

References (33)

1. Albertsson M. Chemoradiotherapy of esophageal cancer. Acta Oncol 2002; 41: 118-123.
2. Muller JM, Erasmi H, Stelzner M et al. Surgical therapy of oesophageal carcinoma. Br J Surg 1990; 77: 845-857.
3. Wobst A, Audisio RA, Colleoni M, Geraghty JG. Oesophageal cancer treatment: studies, strategies and facts. Ann Oncol 1998; 9: 951-962.
4. Forastiere AA, Orringer MB, Perez-Tamayo C et al. Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: final report. J Clin Oncol 1993; 11: 1118-1123.
5. Bates BA, Detterbeck FC, Bernard SA et al. Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma. J Clin Oncol 1996; 14: 156-163.
6. Stahl M, Wilke H, Fink U et al. Combined preoperative chemotherapy and radiotherapy in patients with locally advanced esophageal cancer. Interim analysis of a phase II trial. J Clin Oncol 1996; 14: 829-837.
7. Adelstein DJ, Rice TW, Becker M et al. Use of concurrent chemotherapy, accelerated fractionation radiation, and surgery for patients with esophageal carcinoma. Cancer 1997; 80: 1011-1020.
8. Stockeld D, Tennvall J, Wagenius G et al. A Swedish study of chemoradiation in squamous cell carcinoma of the esophagus. Acta Oncol 2001; 40: 566-573.
9. Nygaard K, Hagen S, Hansen HS et al. Preoperative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of peroperative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. J Surg 1992; 16: 1104-1109.
10. Le Prise E, Etienne PL, Meunier B et al. A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 1994; 73: 1779-1784.
11. Apinop C, Puttisak P, Preecha N. A prospective study of combined therapy in esophageal cancer. Hepatogastroenterology 1994; 41: 391-393.
12. Walsh TN, Noonan N, Hollywood D et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996; 335: 462-467.
13. Bosset JF, Gignoux M, Triboulet JP et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous cell cancer of the esophagus. N Engl J Med 1997; 337: 161-167.
14. Urba SG, Orringer MB, Turrisi A et al. A randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal cancer. J Clin Oncol 2000; 19: 303-313.
15. Burmeister BH, Smithers BM, Fitzgerald L et al. A randomized phase III trial of preoperative chemoradiation followed by surgery versus surgery alone for localized resectable cancer of the esophagus [abstract]. Proc Am Soc Clin Oncol 2002; 21: 130a. Available from URL: http://www.asco.org/asco/meetings_education/2002posters/Abstract518/ poster.htm (1 October 2003, date last accessed).
16. Lee JL, Kim SB, Jung HY et al. Efficacy of neoadjuvant chemoradiotherapy in resectable esophageal squamous cell carcinoma. A single institutional study. Acta Oncol 2003; 42: 207-217.
17. Fleming ID, Cooper JS, Henson DE et al. (eds). AJCC Cancer Staging Manual. 5th edition. Philadelphia, PA: JB Lippincott-Raven 1997; 65-69.
18. Kaplan EL, Meier P. Nonparametric estimation for incomplete observation. J Am Stat Assoc 1958; 53: 457-481.
19. Mantel N. Evaluation of survival and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163-170.
20. Freedman LS. Tables of the number of patients required in clinical trials using the log-rank test. Stat Med 1982; 1: 121-129.
21. O'Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics 1979; 35: 549-556.
22. Urschel JD, Vasan H. A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg 2003; 185: 538-543.
23. Kelsen DP, Ginsberg R, Pajak T et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 1998; 339: 1979-1984.
24. Girling DJ, The Medical Research Council Oesophageal Cancer Working Party. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomized controlled trial. Lancet 2002; 359: 1727-1733.
25. Hulscher JBF, van Sandick JW, de Boer AGEM et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002; 347: 1662-1669.
26. Powell ME, Hoskin PJ, Saunders MI et al. Continuous hyperfractionated accelerated radiotherapy (CHART) in localized cancer of the esophagus. Int J Radiat Oncol Biol Phys 1997; 38: 133-136.
27. Jeremic B, Shibamoto Y, Acimovic L et al. Accelerated hyperfractionated radiation therapy and concurrent 5-fluorouracil/cisplatin chemotherapy for locoregional squamous cell carcinoma of the thoracic esophagus: a phase II study. Int J Radiat Oncol Biol Phys 1998; 40: 1061-1066.
28. Thames HD, Peters LJ, Withers HR et al. Accelerated fractionation vs hyperfractionation: rationales for several treatments per day. Int J Radiat Oncol Biol Phys 1983; 9: 127-138.
29. Heath EI, Burtness BA, Heitmiller RF et al. Phase II evaluation of preoperative chemoradiation and postoperative adjuvant chemotherapy for squamous cell and adenocarcinoma of the esophagus. J Clin Oncol 2000; 18: 868-876.
30. Hoff SJ, Stewart JR, Sawyers JL et al. Preliminary results with neoadjuvant therapy and resection for esophageal carcinoma. Ann Thorac Surg 1993; 56: 282-286.
31. Raoul JL, Le Prise E, Meunier B et al. Neoadjuvant chemotherapy and hyperfractionated radiotherapy with concurrent low dose chemotherapy for squamous cell carcinoma. Int J Radiat Oncol Biol Phys 1998; 42: 29-34.
32. Wright CD, Wain JC, Lynch TJ et al. Induction therapy for esophageal carcinoma with paclitaxel and hyperfractionated radiotherapy: a phase I and II study. J Thorac Cardiovasc Surg 1997; 114: 811-816.
33. Nguyen NP, Leonardo JM, Karlsson U et al. Preoperative chemotherapy and radiation for advanced esophageal carcinoma: comparison between once a day radiation and hyperfractionation, a single-institution experience. Am J Clin Oncol 2002; 25: 358-364.